Glutamate AMPA receptor subunit 1 gene (GRIA1) and DSM-IV-TR schizophrenia:: A pilot case-control association study in an Italian sample

Glutamate AMPA receptor subunit 1 gene (GRIA1) and DSM-IV-TR schizophrenia:: A pilot case-control association study in an Italian sample
复制标题

DOI:
10.1002/ajmg.b.30294
复制
发表时间:
2006-04-05
影响因子:
2.8
通讯作者:
Barlati, S
Barlati, S
中科院分区:
医学3区
文献类型:
--
作者:
Magri, C;Gardella, R;Barlati, S

文献摘要

被引文献

相似文献

谷氨酸能功能障碍是精神分裂症发病机制的主要假说之一。GRLA1基因编码四个(GluR1-4)嗜离子性AMPA受体亚基中的一个(GluR1)。GRLA1是一个很好的精神分裂症易感性候选基因,因为它定位于5q33,这是一个易感性位点存在的区域,独立的全基因组扫描表明,因为它的表达在一些精神分裂症患者的大脑中被发现减少。我们介绍了一项意大利人群的病例对照关联研究数据,该研究涉及整个GRIA1基因的8个多态性。单位点分析显示,两个snp (rs707176, 0.41 vs. 0.31, P= 0.009; rs2963944, 0.41 vs. 0.30, P= 0.007)和一个微卫星(rs10631988,等位基因9:0.40 vs. 0.29, P=0.004)的等位基因分布在病例和对照组中存在显著差异。单倍型分析显示,这些标记的特定单倍型频率增加(C09CC, 0.39 vs. 0.28, P=0.009)。因此,我们的数据表明,GRIA1可能与DSM-IV-TR精神分裂症的易感性有关。(c) 2006 Wiley-Liss, Inc。
Glutamatergic dysfunction is one of the major hypotheses for the pathogenesis of schizophrenia. The GRLA1 gene encodes for one (GluR1) of the four (GluR1-4) ionotropic AMPA receptor subunits. GRLA1 is a good candidate gene for susceptibility to schizophrenia since it maps in 5q33, a region where the presence of susceptibility loci has been suggested by independent genome-wide scans and because its expression has been found to be decreased in the brain of some schizophrenia patients. We present data from a case-control association study on the Italian population with eight polymorphisms spanning the whole GRIA1 gene. Single-locus analysis revealed a significantly different allele distribution in cases and in controls of two SNPs (rs707176, 0.41 vs. 0.31, P = 0.009; rs2963944, 0.41 vs. 0.30, P = 0.007), and one microsatellite (rs10631988, allele 9: 0.40 vs. 0.29, P=0.004). Haplotype analysis showed an increased frequency of a specific haplotype for these markers (C09CC, 0.39 vs. 0.28, P=0.009). Therefore our data indicate that GRIA1 may be involved in susceptibility to DSM-IV-TR schizophrenia. (c) 2006 Wiley-Liss, Inc.